logo

News

    • 23RD MARCH 2023

    MHRA Class 2 Medicines Recall: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited)

    Drug alert number: EL(23)A/12 Date issued: 23 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited) Batch number Expiry date Pack size First distributed T16656K Mar 2024 1 19 May 2022 U11271E Jun

    Read more
    • 22ND MARCH 2023

    15 MPs take part in a community pharmacy emergency summit

    England’s community pharmacies received strong Parliamentary backing yesterday with 15 MPs represented at a PSNC-coordinated roundtable, as part of the wider Save Our Pharmacies campaign. Sector leaders attended the summit, which was chaired by Stephen Hammond MP, to brief MPs on the severe challenges facing the sector. The attendees included: Janet Morrison Chief Executive, PSNC

    Read more
    • 22ND MARCH 2023

    Just over a week left to submit valproate audit data

    6,514 contractors have submitted their valproate audit data; have you submitted your data yet? By 31st March 2023, all community pharmacy contractors must have completed the 2022/23 national clinical audit on valproate over a six-week consecutive period and have submitted their data via the Valproate audit 2022/23 tab on MYS. This is a mandatory contractual

    Read more
    • 22ND MARCH 2023

    March 2023 Price Concessions 2nd Update

    The Department of Health and Social Care (DHSC) has today (22/03/2023) granted the following list of price concessions for March 2023. Drug Pack size Price concession Bisoprolol 2.5mg tablets 28 £1.18 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment 30 £10.29 Clarithromycin 250mg/5ml oral suspension 70 £5.54 Clotrimazole 1% cream 20 £2.29 Co-codamol 30mg/500mg effervescent tablets 32

    Read more
    • 21ST MARCH 2023

    PQS: NHSE publishes 2019/20 high risk audit report

    NHS England (NHSE) has published a report on the high risk medicines audit* from the 2019/20 Pharmacy Quality Scheme (PQS). 10,673 (90%) community pharmacy contractors participated in the audit and 40,419 patients were audited. This audit shows that pharmacists and pharmacy teams have a very important role in ensuring that high risk medicines are understood

    Read more
    • 21ST MARCH 2023

    MHRA Class 3 Medicines Recall: Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd)

    Drug alert number: EL(23)A/11 Date issued: 21 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd) – PL 00427/0258 Batch Number Expiry Date Pack Size First Distributed SLD22002 April 2025 122ml June 2022 Active Pharmaceutical Ingredients: Sildenafil (as Citrate)

    Read more
    • 20TH MARCH 2023

    Peers hold parliamentary debate on community pharmacy

    Community pharmacies received strong backing today in the House of Lords, with a number of Peers speaking out in support of pharmacies and others asking when Government would address the current crisis in the sector. The House of Lords oral questions session was opened by Baroness Hodgson on behalf of Baroness Cumberlege as follows: “To

    Read more
    • 20TH MARCH 2023

    PSNC Elections – final stage of voting

    Contractors are currently voting in four PSNC regional representative ballots and PSNC’s (national) non-CCA Multiple representatives ballot. We have been requesting for contractors to make their vote as soon as possible before the voting deadlines. The voting allocations for the ballots are based on records of contractors’ NHS pharmacy premises and earlier this year contractors

    Read more
    • 20TH MARCH 2023

    Save our Pharmacies campaign gains momentum

    Pharmacy leaders are set to brief MPs on the severe challenges facing community pharmacies this week as part of a wave of #SaveOurPharmacies campaign activities. Tomorrow’s (Tuesday 21st March) roundtable summit will include discussions on the urgent action needed to address the current severe challenges being faced by community pharmacy, as well as the sector’s

    Read more
    • 17TH MARCH 2023

    SSP issued for Paracetamol 240mg suppositories

    In response to a significant ongoing disruption to the supply of Paracetamol 240mg suppositories , a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 17 March 2023, SSP051 provides that for every Paracetamol 240mg suppository originally prescribed, one Paracetamol 250mg suppository must be supplied. SSP051, authorised by the

    Read more
© 2025 Middlesex Pharmaceutical Group